Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ACAT inhibitors from Nihon Nohyaku

April 22, 1997

Cholesterol biosynthesis inhibitors described by Nippon Soda

April 21, 1997

Teijin and Microbial Chemistry Research Foundation reveal acetyl-CoA carboxylase inhibitor

April 21, 1997

Novavax completes phase Ia trial of generic human testosterone drug

April 21, 1997

Antidiabetic coumarin derivatives from Otsuka

April 21, 1997

Alteon reports positive results from phase II trials with pimagedine

April 18, 1997

Atorvastatin available in Germany for hyperlipidemia

April 18, 1997

Positive phase I data reported for liposomal PGE1 product for erectile dysfunction

April 18, 1997

Inhibitors of ICE and ICE-like proteins claimed by SmithKline Beecham

April 18, 1997

Genome Therapeutics and Creighton University pursue genes associated with osteoporosis

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...